169 related articles for article (PubMed ID: 34332864)
1. [Vaccination against community acquired pneumonia in adults. Update 2021 of the position paper by Neumoexpertos en Prevención Group].
Redondo E; Rivero-Calle I; Mascarós E; Yuste JE; Fernández-Prada M; Ocaña D; Jimeno I; Gil A; Molina J; Díaz-Maroto JL; Linares M; Martinón-Torres F;
Semergen; 2021 Sep; 47(6):411-425. PubMed ID: 34332864
[TBL] [Abstract][Full Text] [Related]
2. [Vaccination against community acquired pneumonia in adult patients. A position paper by Neumoexpertos en Prevención].
Redondo E; Rivero I; Vargas DA; Mascarós E; Díaz-Maroto JL; Linares M; Valdepérez J; Gil A; Molina J; Jimeno I; Ocaña D; Martinón-Torres F;
Semergen; 2016 Oct; 42(7):464-475. PubMed ID: 27641310
[TBL] [Abstract][Full Text] [Related]
3. [Adult community acquired pneumonia vaccination: 2018 Update of the positioning of the Pneumonia Prevention Expert Group].
Redondo E; Rivero-Calle I; Vargas DA; Mascarós E; Díaz-Maroto JL; Linares M; Gil A; Molina J; Jimeno I; Ocaña D; Yuste JE; Martinón-Torres F;
Semergen; 2018; 44(8):590-597. PubMed ID: 30318406
[TBL] [Abstract][Full Text] [Related]
4. Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group.
Redondo E; Rivero-Calle I; Mascarós E; Ocaña D; Jimeno I; Gil Á; Díaz-Maroto JL; Linares M; Onieva-García MÁ; González-Romo F; Yuste J; Martinón-Torres F
Antibiotics (Basel); 2023 Jan; 12(1):. PubMed ID: 36671339
[TBL] [Abstract][Full Text] [Related]
5. Impact of vaccination on the epidemiology and prognosis of pneumonia.
Luna CM
Rev Esp Quimioter; 2022 Apr; 35 Suppl 1(Suppl 1):104-110. PubMed ID: 35488837
[TBL] [Abstract][Full Text] [Related]
6. Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines.
Principi N; Esposito S
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28029140
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the change in pneumococcal vaccination in 2018 in adults in the Community of Madrid].
Beca Martínez MT; Morey Montalvo M; Santos Sanz S; Barrio Cortes J; Cañellas Llabrés S; Lasheras Carbajo MD
Semergen; 2021; 47(4):240-247. PubMed ID: 33865695
[TBL] [Abstract][Full Text] [Related]
8. Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adults.
Isturiz R; Webber C
Hum Vaccin Immunother; 2015; 11(7):1825-7. PubMed ID: 26076136
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
Baldo V; Cocchio S; Gallo T; Furlan P; Romor P; Bertoncello C; Buja A; Baldovin T
PLoS One; 2016; 11(11):e0166637. PubMed ID: 27846277
[TBL] [Abstract][Full Text] [Related]
10. The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: Exploratory analysis of the CAPiTA trial.
Huijts SM; Coenjaerts FEJ; Bolkenbaas M; van Werkhoven CH; Grobbee DE; Bonten MJM;
Clin Microbiol Infect; 2018 Jul; 24(7):764-770. PubMed ID: 29050992
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal vaccines and the prevention of community-acquired pneumonia.
Esposito S; Principi N
Pulm Pharmacol Ther; 2015 Jun; 32():124-9. PubMed ID: 24607597
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of Streptococcus pneumoniae (pneumococcal) infections in adults].
Ludwig E; Mészner Z;
Orv Hetil; 2014 Dec; 155(50):1996-2004. PubMed ID: 25481502
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.
Walters JA; Tang JN; Poole P; Wood-Baker R
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD001390. PubMed ID: 28116747
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study.
Ochoa-Gondar O; Vila-Corcoles A; Rodriguez-Blanco T; Gomez-Bertomeu F; Figuerola-Massana E; Raga-Luria X; Hospital-Guardiola I
Clin Infect Dis; 2014 Apr; 58(7):909-17. PubMed ID: 24532544
[TBL] [Abstract][Full Text] [Related]
15. A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands.
Gessner BD; Jiang Q; Van Werkhoven CH; Sings HL; Webber C; Scott D; Gruber WC; Grobbee DE; Bonten MJM; Jodar L
Vaccine; 2019 Jul; 37(30):4147-4154. PubMed ID: 31155413
[TBL] [Abstract][Full Text] [Related]
16. Community-acquired pneumonia among smokers.
Almirall J; Blanquer J; Bello S
Arch Bronconeumol; 2014 Jun; 50(6):250-4. PubMed ID: 24387877
[TBL] [Abstract][Full Text] [Related]
17. [Pneumococcal vaccine recommendations in chronic respiratory diseases].
Casas Maldonado F; Alfageme Michavila I; Barchilón Cohen VS; Peis Redondo JI; Vargas Ortega DA
Semergen; 2014 Sep; 40(6):313-25. PubMed ID: 25107494
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal conjugate vaccine use in adults - Addressing an unmet medical need for non-bacteremic pneumococcal pneumonia.
Sings HL
Vaccine; 2017 Sep; 35(40):5406-5417. PubMed ID: 28602602
[TBL] [Abstract][Full Text] [Related]
19. Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?
van Werkhoven CH
Hum Vaccin Immunother; 2017 May; 13(5):1177-1181. PubMed ID: 27937061
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design.
McLaughlin JM; Jiang Q; Isturiz RE; Sings HL; Swerdlow DL; Gessner BD; Carrico RM; Peyrani P; Wiemken TL; Mattingly WA; Ramirez JA; Jodar L
Clin Infect Dis; 2018 Oct; 67(10):1498-1506. PubMed ID: 29790925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
